Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
37.48
-3.09 (-7.62%)
At close: Oct 10, 2025, 4:00 PM EDT
37.95
+0.47 (1.25%)
After-hours: Oct 10, 2025, 7:58 PM EDT
Harrow Market Cap
Harrow has a market cap or net worth of $1.39 billion as of October 10, 2025. Its market cap has decreased by -14.87% in one year.
Market Cap
1.39B
Enterprise Value
1.56B
1-Year Change
-14.87%
Ranking
Category
Stock Price
$37.48
Market Cap Chart
Since March 31, 2009, Harrow's market cap has increased from $14.00M to $1.39B, an increase of 9,806.00%. That is a compound annual growth rate of 32.04%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 9, 2025 | 1.50B | 25.63% |
Dec 31, 2024 | 1.19B | 203.81% |
Dec 29, 2023 | 393.30M | -2.79% |
Dec 30, 2022 | 404.60M | 74.10% |
Dec 31, 2021 | 232.40M | 31.60% |
Dec 31, 2020 | 176.60M | -9.81% |
Dec 31, 2019 | 195.80M | 47.77% |
Dec 31, 2018 | 132.50M | 279.66% |
Dec 29, 2017 | 34.90M | 5.44% |
Dec 30, 2016 | 33.10M | -50.67% |
Dec 31, 2015 | 67.10M | -3.31% |
Dec 31, 2014 | 69.40M | 130.56% |
Dec 31, 2013 | 30.10M | -53.19% |
Dec 31, 2012 | 64.30M | 3,284.21% |
Dec 30, 2011 | 1.90M | -85.04% |
Dec 31, 2010 | 12.70M | -45.96% |
Dec 31, 2009 | 23.50M | 67.86% |
Mar 31, 2009 | 14.00M | - |
View and export this data all the way back to 2009. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 767.88B |
Johnson & Johnson | 460.19B |
AbbVie | 407.53B |
UnitedHealth Group | 333.01B |
AstraZeneca | 266.87B |
Novo Nordisk | 261.06B |
Novartis AG | 256.06B |
Abbott Laboratories | 232.02B |